FdaApplication

ANDA 075390

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAUROBINDO PHARMA USA INC
application_typeANDA
approval_date2001-04-19

Products (2)

ProductActive ingredientStrengthDosage form
NAPROXENNAPROXEN375MGTABLET, DELAYED RELEASE;ORAL
NAPROXENNAPROXEN500MGTABLET, DELAYED RELEASE;ORAL

2 products